Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000480674 | SCV000572008 | uncertain significance | not provided | 2018-02-02 | criteria provided, single submitter | clinical testing | This variant is denoted POLE c.-47G>T and describes a nucleotide substitution 47 base pairs upstream of the ATG translational start site in the 5' untranslated region (UTR). The surrounding sequence, with the base that is substituted in braces, is GGGA[G/T]CGCG. This variant has not, to our knowledge, been published in the literature as pathogenic or benign. This variant does not affect the start codon or the Kozak translational consensus sequence. POLE c.-47G>T occurs at a position that is conserved in mammals. This variant was not observed in approximately 3,700 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, suggesting it is not a common benign variant in these populations. Based on currently available evidence, it is unclear whether POLE c.-47G>T is a pathogenic or benign variant. We consider it to be a variant of uncertain significance. |
Fulgent Genetics, |
RCV002475942 | SCV002783410 | uncertain significance | Colorectal cancer, susceptibility to, 12; Facial dysmorphism-immunodeficiency-livedo-short stature syndrome; Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency | 2022-03-11 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV003493600 | SCV004242571 | likely benign | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing |